{
    "title": "105_hr1398",
    "content": "The \"Parkinson's Research Act of 1997\" aims to expand federal investment in Parkinson's research and improve coordination among National Institutes of Health research institutes. It also seeks to enhance care and assistance for individuals with Parkinson's and their family caregivers. The Director of NIH will establish a program for Parkinson's disease research and training, coordinating with national research institutes and holding research planning conferences. Additionally, Core Center Grants will be awarded to promote innovative research. The Director of NIH will award Core Center Grants to establish Morris K. Udall Research Centers for Parkinson's disease research. Each center must conduct basic and clinical research on Parkinson's and meet specific qualifications set by the Director. The Morris K. Udall Research Centers for Parkinson's disease research conduct basic and clinical research, provide training programs, disseminate information to the public, and establish a nationwide data system. The Morris K. Udall Research Centers for Parkinson's disease research conduct basic and clinical research, provide training programs, disseminate information to the public, and establish a nationwide data system. The centers also aim to enhance knowledge and understanding of Parkinson's disease through an Information Clearinghouse and a national education program. Stipends may be provided for scientists and health professionals in training programs, with support lasting up to five years. The Director of NIH may extend support for a Parkinson's disease research center for up to five years, with the possibility of additional extensions. A grant program will be established to support researchers in Parkinson's research for a maximum of five years. $100,000,000 is authorized for carrying out these initiatives. Authorization of appropriations up to $100,000,000 for Parkinson's research for fiscal year 1998, with additional funding for subsequent years. Restrictions on the use of funds for research involving human fetal tissue."
}